Immune cell signatures and preeclampsia: Unveiling causal links through genome-wide association studies
Open Access
- 9 January 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (2) , e46002
Abstract
The immune-placental interaction could potentially contribute both causally and therapeutically to preeclampsia (PE). However, previous observational studies have not demonstrated a causal association between these 2 factors. Exploring the causal relationship between immune cells and PE provides genetic evidence that immune cells play a role in PE risk. Using a large dataset of genome-wide association studies, we conducted a bidirectional Mendelian randomization (MR) analysis to determine whether 731 immune cell signatures were correlated with PE, which included 4 types of immune signatures. After false discovery rate (FDR) correction, 3 immunophenotypes were identified to be significantly associated with PE risk: human leukocyte antigen on dendritic cells (odds ratio [OR] = 1.072, 95% confidence interval [CI] = 1.0352–1.110, P FDR = .012), absolute T cell count (OR = 1.477, 95% CI = 1.281–1.703, P FDR = 1.71 × 10 −5 ), and absolute lymphocyte count (OR = 1.514, 95% CI = 1.306–1.755, P FDR = 1.58 × 10 −5 ). Furthermore, PE did not affect immunophenotypes significantly after FDR adjustment, but 12 suggestive immunophenotypes were detected without FDR adjustment, including CD3 on activated and secreting CD4 regulatory T cell ( β = 0.467, P = .039), CD3 on CD39 + CD4 + T cell ( β = 0.508, P = .024), CD3 on CD45RA + CD4 + T cell ( β = 0.515, P = .022), CD3 on CD28 + CD45RA + CD8 + T cell ( β = 0.494, P = .028), CD3 on CD39 + CD8 + T cell ( β = 0.486, P = .029), CD45 on HLA DR + CD8 + T cell ( β = 0.518, P = .018), CD3 on secreting CD4 regulatory T cell ( β = 0.508, P = .025), CD25 on resting CD4 regulatory T cell ( β = 0.496, P = .018), CD4 on CD39 + activated CD4 regulatory T cell ( β = 0.445, P = .048), CD3 on CD28 + CD45RA − CD8 + T cell ( β = 0.498, P = .024), CD3 on effector memory CD4 + T cell ( β = 0.614, P = .007), and CD3 on activated CD4 regulatory T cell( β = 0.444, P = .049). Using genetic methods, this study uncovers the close relationship between immune cells and PE, which provides guidance for future clinical trials.Keywords
This publication has 34 references indexed in Scilit:
- Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patientsPregnancy Hypertension, 2020
- Reduced ELABELA expression attenuates trophoblast invasion through the PI3K/AKT/mTOR pathway in early onset preeclampsiaPlacenta, 2019
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and preventionInternational Journal of Gynecology & Obstetrics, 2019
- Absolute lymphocyte count and human adenovirus–specific T‐cell immune restoration of human adenovirus infection after kidney transplantationJournal of Medical Virology, 2019
- HLA-DR is aberrantly expressed at feto-maternal interface in pre-eclampsiaJournal of Reproductive Immunology, 2018
- Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesisAmerican Journal of Obstetrics and Gynecology, 2018
- Increased circulating Th22 cells correlated with Th17 cells in patients with severe preeclampsiaHypertension in Pregnancy, 2016
- Vascular endothelial growth factor affects dendritic cell activity in hypertensive disorders of pregnancyMolecular Medicine Reports, 2015
- Distinct subsets of regulatory T cells during pregnancy: Is the imbalance of these subsets involved in the pathogenesis of preeclampsia?Clinical Immunology, 2008
- Preeclampsia, a Pregnancy-Specific Disease, Is Associated with Fetal Monocyte ActivationClinical Immunology, 2001